» Articles » PMID: 33150562

Influences of Xeno-Free Media on Mesenchymal Stem Cell Expansion for Clinical Application

Overview
Date 2020 Nov 5
PMID 33150562
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Mesenchymal stem/stromal cells (MSCs) are multipotent somatic stem/progenitor cells that can be isolated from various tissues and have attracted increasing attention from the scientific community. This is due to MSCs showing great potential for incurable disease treatment, and most applications of MSCs involve tissue degeneration and treatment of immune- and inflammation-mediated diseases. Conventional MSC cultures contain fetal bovine serum (FBS), which is a common supplement for cell development but is also a risk factor for exposure to animal-derived pathogens. To avoid the risks resulting from the xenogeneic origin and animal-derived pathogens of FBS, xeno-free media have been developed and commercialized to satisfy MSC expansion demands for human clinical applications. This review summarized and provided an overview of xeno-free media that are currently used for MSC expansion. Additionally, we discussed the influences of different xeno-free media on MSC biology with particular regard to cell morphology, surface marker expression, proliferation, differentiation and immunomodulation. The xeno-free media can be serum-free and xeno-free media or media supplemented with some human-originating substances, such as human serum, human platelet lysates, human umbilical cord serum/plasma, or human plasma-derived supplements for cell culture medium. These media have capacity to maintain a spindle-shaped morphology, the expression of typical surface markers, and the capacity of multipotent differentiation and immunomodulation of MSCs. Xeno-free media showed potential for safe use for human clinical treatment. However, the influences of these xeno-free media on MSCs are various and any xeno-free medium should be examined prior to being used for MSC cultures.

Citing Articles

The roles of regulatory-compliant media and inflammatory/oxytocin priming selection in enhancing human mesenchymal stem/stromal cell immunomodulatory properties.

Gardashli M, Baron M, Drohat P, Quintero D, Kaplan L, Szeto A Sci Rep. 2024; 14(1):29438.

PMID: 39604514 PMC: 11603324. DOI: 10.1038/s41598-024-80050-9.


Manufacturing exosomes for wound healing: Comparative analysis of culture media.

Dao H, Nguyen T, Hoang D, Vu B, Tran M, Le M PLoS One. 2024; 19(11):e0313697.

PMID: 39541412 PMC: 11563385. DOI: 10.1371/journal.pone.0313697.


Comparative Analysis of Serum and Serum-Free Medium Cultured Mesenchymal Stromal Cells for Cartilage Repair.

Kang M, Yang Y, Zhang H, Zhang Y, Wu Y, Denslin V Int J Mol Sci. 2024; 25(19).

PMID: 39408956 PMC: 11476526. DOI: 10.3390/ijms251910627.


Evaluation of the impact of customized serum-free culture medium on the production of clinical-grade human umbilical cord mesenchymal stem cells: insights for future clinical applications.

Zhao L, Ni B, Li J, Liu R, Zhang Q, Zheng Z Stem Cell Res Ther. 2024; 15(1):327.

PMID: 39334391 PMC: 11438183. DOI: 10.1186/s13287-024-03949-0.


Enhanced anti-tumor efficacy with multi-transgene armed mesenchymal stem cells for treating peritoneal carcinomatosis.

Ho Y, Woo J, Loke K, Deng L, Too H J Transl Med. 2024; 22(1):463.

PMID: 38750559 PMC: 11097589. DOI: 10.1186/s12967-024-05278-5.


References
1.
Qin Y, Guan J, Zhang C . Mesenchymal stem cells: mechanisms and role in bone regeneration. Postgrad Med J. 2014; 90(1069):643-7. PMC: 4215372. DOI: 10.1136/postgradmedj-2013-132387. View

2.
Mojica-Henshaw M, Jacobson P, Morris J, Kelley L, Pierce J, Boyer M . Serum-converted platelet lysate can substitute for fetal bovine serum in human mesenchymal stromal cell cultures. Cytotherapy. 2013; 15(12):1458-68. DOI: 10.1016/j.jcyt.2013.06.014. View

3.
Kandoi S, L P, Patra B, Vidyasekar P, Sivanesan D, S V . Evaluation of platelet lysate as a substitute for FBS in explant and enzymatic isolation methods of human umbilical cord MSCs. Sci Rep. 2018; 8(1):12439. PMC: 6102222. DOI: 10.1038/s41598-018-30772-4. View

4.
Li L, Li F, Gao F, Yang Y, Liu Y, Guo P . Transplantation of mesenchymal stem cells improves type 1 diabetes mellitus. Cell Tissue Res. 2015; 364(2):345-55. DOI: 10.1007/s00441-015-2330-5. View

5.
Feng Y, Zhan F, Zhong Y, Tan B . Effects of human umbilical cord mesenchymal stem cells derived from exosomes on migration ability of endometrial glandular epithelial cells. Mol Med Rep. 2020; 22(2):715-722. PMC: 7339775. DOI: 10.3892/mmr.2020.11137. View